Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israel Signs Deal With Novavax for COVID Vaccine, Health Ministry Says
Error: Contact form not found.
by Reuters and Algemeiner Staff
A technician is reflected in a surface as she works at Healthcare Maintenance Organisation (HMO) Maccabi’s coronavirus disease (COVID-19) public laboratory, performing diverse and numerous tests, in Rehovot, Israel February 9, 2021. REUTERS/Ammar Awad
Israel has signed a deal to buy 5 million COVID-19 vaccine doses from Novavax, the Health Ministry said on Friday.
The vaccines are due to arrive in Israel in the coming months, pending regulatory approval. Financial details of the deal, which includes the option for an additional 5 million doses, were not disclosed.
Novavax’s protein-based vaccine will be administered in two doses and has been found effective against a number of variants, the ministry said. It will be an alternative for those who do not want a vaccine that uses messenger RNA (mRNA) technology.
Mostly Israelis have received the Pfizer/BioNTech vaccine or other vaccines that use mRNA to spur an immune response.
The ministry said Novavax’s vaccine has been approved by regulators in Europe and is still being examined by the US Food and Drug Administration.
